2017: HLA TWIN V2.1 New Release

03/03/2017

Omixon announce today a major release for HLA Twin – the world’s most accurate, high throughput HLA genotyping software. HLA Twin V2.1 will be available as RUO and a special version will be submitted to the European Notified Body for CE-IVD certification. Thanks to the beta testers of V2.1,...

Replacement Organs – Types, Basics, Expectations

27/02/2017

If we take a look back at 2016 to find the biggest scientific achievements and think about the the challenges that life scienctists are facing we find that one of the most interesting and developing areas is tissue engineering for growing artificial organs in the lab. It’s not surprising that...

Take a Selfie to be Featured in Our Rock Video!

13/02/2017

Grab your mobile, take a selfie or headshot of your colleagues, send it to us and enjoy the red carpet for a minute! As usual, we are going to cheer-up our audience before our Lunch Symposium at the European Immunogenetics and Histocompatibility Conference (EFI) in May with a short...

Omixon Symposium at the Upcoming EWIC 2017 Conference

06/02/2017

Omixon is proud to announce that we are one of the Silver Sponsors of the Annual EWIC 2017 Conference. Marcello Scala (Director of Sales, EMEA) and Dr. Libor Kolesár (Field Application Scientist) will announce major improvements to the existing products during a commercial presentation. Title of the presentation: “Omixon V.2...

2017: An Omixon Odyssey – A Letter from CEO, Tim Hague

30/01/2017

Dear Customers and Friends of Omixon, After a prosperous finish to 2016, I would like you to be the first to know about three major announcements concerning Omixon’s evolution for 2017, in the HLA community and beyond. First, in the next few weeks, we will be launching Holotype...